Skip to main content
. 2018 Jul 20;67(28):773–777. doi: 10.15585/mmwr.mm6728a2

FIGURE 3.

The figure above is a line chart showing the reported annual cost of treatment for hepatitis B virus infection with tenofovir in countries that can access generic medicines, worldwide, during 2004–2016.

Reported annual cost of treatment for hepatitis B virus infection with tenofovir in countries that can access generic medicines — worldwide, 2004–2016

Source: World Health Organizations Global Price Reporting Mechanism.